Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory decline and subsequent loss of broader cognitive functions 1 . Memory decline in the early stages of AD is mostly limited to episodic memory, for which the hippocampus has a crucial role 2 . However, it has been uncertain whether the observed amnesia in the early stages of AD is due to disrupted encoding and consolidation of episodic information, or an impairment in the retrieval of stored memory information. Here we show that in transgenic mouse models of early AD, direct optogenetic activation of hippocampal memory engram cells results in memory retrieval despite the fact that these mice are amnesic in long-term memory tests when natural recall cues are used, revealing a retrieval, rather than a storage impairment. Before amyloid plaque deposition, the amnesia in these mice is age-dependent 3-5 , which correlates with a progressive reduction in spine density of hippocampal dentate gyrus engram cells. We show that optogenetic induction of longterm potentiation at perforant path synapses of dentate gyrus engram cells restores both spine density and long-term memory. We also demonstrate that an ablation of dentate gyrus engram cells containing restored spine density prevents the rescue of long-term memory. Thus, selective rescue of spine density in engram cells may lead to an effective strategy for treating memory loss in the early stages of AD.
in memory encoding ( Fig. 1k-o) . By contrast, 7-month-old AD mice showed normal levels of training-induced freezing ( Fig. 1f ) and normal STM (Fig. 1g ), but were impaired in LTM (Fig. 1h ). Neither control nor 7-month-old AD mice displayed freezing behaviour in a neutral context (Fig. 1i ). In the DG of 7-month-old AD mice, the levels of cells that were immediate early gene c-Fos-positive after CFC training were normal, but were lower compared with control mice after LTM tests (Fig. 1j) . Motor behaviours and the density of DG granule cells were normal in these mice (Extended Data Fig. 1e-k) . Thus, these behavioural-and cellular-level observations confirmed that 7-month-old AD mice serve as a mouse model of early AD regarding memory impairments.
Recently, molecular, genetic and optogenetic methods to identify neurons that hold traces, or engrams, of specific memories have been established 11, 12 . Using this technology, several groups have demonstrated that DG neurons activated during CFC learning are both sufficient [11] [12] [13] [14] and necessary 15 for subsequent memory retrieval. In addition, our recent study found that engram cells under protein-synthesisinhibitor-induced amnesia were capable of driving acute memory recall if they were directly activated optogenetically 14 . Here, we applied this memory engram cell identification and manipulation technology to 7-month-old AD mice to determine whether memories could be retrieved in the early stages of the disease. Because it is known that the EC-hippocampus (HPC) network is among the earliest to show altered synaptic/dendritic properties and these alterations have been suggested to underlie the memory deficits in early AD 16, 17 , we focused on labelling the DG component of CFC memory engram cells of 7-month-old AD mice using a double adeno-associated virus (AAV) system (Fig. 1p , q and Methods). Although on a doxycycline (DOX) diet DG neurons completely lacked channelrhodopsin 2 (ChR2)-enhanced yellow fluorescent protein (eYFP) labelling, 1 day off DOX was sufficient to permit robust ChR2-eYFP expression in control mice (Fig. 1r, s and Extended Data Fig. 2a -c), as well as in 7-month-old AD mice ( Fig. 1t, u) .
As expected, these engram-labelled early AD mice were amnesic a day after CFC training (Fig. 1v ). But, remarkably, these mice froze on the next day in a distinct context (context B) as robustly as equivalently treated control mice in response to blue light stimulation of the engram cells (Fig. 1w ). This light-specific freezing was not observed using on-DOX mice (Extended Data Fig. 2d-f) . A natural recall test conducted on the third day in the conditioning context (context A) revealed that the observed optogenetic engram reactivation did not restore memory recall by natural cues in early AD mice (Fig. 1x ). This was the case even after multiple rounds of light activation of the engram cells (Extended Data Fig. 3 ). We replicated the successful optogenetic rescue of memory recall in two other models of early AD: a triple transgenic line obtained by mating c-Fos-tTA mice with double-transgenic APP/PS1 mice (Extended Data Fig. 4a -g) and a widely used triple-transgenic AD model 18 (PS1/APP/tau (also known as MAPT); Extended Data Fig. 4h-m) . These data show that DG engram cells in 7-month-old mouse models of early AD are sufficient to induce memory recall upon optogenetic reactivation, which indicates a deficit of memory retrievability during early AD-related memory loss.
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Reduced dendritic spines have been implicated in memory impairments of AD 3 . In addition, our recent study of protein-synthesisinhibitor-induced amnesia found reduced engram-cell-specific dendritic spine density 14 . We detected an age-dependent (Extended Data Fig. 5a ) decrease in dendritic spine density of DG engram cells in early AD mice ( Fig. 2a-c) , showing that the long-term memory impairments of early AD correlate with dendritic spine deficits of DG engram cells (Extended Data Fig. 5b ). The inability to generate newborn neurons in the DG could play a part in the development of AD-specific cognitive deficits 19 . However, early AD mice showed similar levels of neurogenesis in the DG compared with control mice, which were quantified using doublecortin (DCX) staining (Extended Data Fig. 1l-q) . We recently proposed that the persistent cellular connectivity between multiple engram cell ensembles is a fundamental mechanism of memory information LETTER RESEARCH retention 14 . We labelled putative CFC memory engram cells in both medial EC (MEC) and lateral EC (LEC) with oChIEF 20 (a variant of ChR2) and simultaneously labelled CFC memory engram cells in the DG with eYFP ( Fig. 2d ). With this procedure, perforant path (PP) terminals are also labelled with oChIEF ( Fig. 2e , f). One day after footshocks, we optogenetically activated these terminals and quantified the overlap between putative DG engram cells (that is, eYFP + , green) and DG cells in which the endogenous c-Fos (red) had been activated by the optogenetic activation of oChIEF + PP terminals. Both control and early AD mice showed above-chance and indistinguishable levels of c-Fos + / eYFP + overlap, indicating that the preferential functional connectivity between engram cells is maintained in the early AD mice ( Fig. 2g -i).
We then hypothesized that the reversal of dendritic spine deficits in DG engram cells of early AD mice may rescue long-term memory. To investigate this possibility, we took advantage of previous findings that spine formation can be induced rapidly by long-term potentiation (LTP) 21, 22 and that LTP can be induced in vivo using light activation of oChIEF 23 . We validated learning-dependent labelling, with oChIEF, of neurons in the MEC (Fig. 3a -c and Extended Data Fig. 6a -c) and LEC ( Fig. 3d ) as well as PP terminals in the DG (Fig. 3e, f) . In vivo extracellular recording upon light stimulation of oChIEF + EC axonal terminals in the DG showed a reliable spiking response of DG cells in anaesthetized control mice ( Fig. 3g ). Furthermore, in HPC slices from control mice we successfully induced LTP in DG cells using a previously established optical LTP protocol 23 (Fig. 3h-j) . These biocytin-filled DG cells revealed an increase in spine density after in vitro optical LTP (Extended Data Fig. 6d ).
In early AD mice, in vivo application of the engram-specific optical LTP protocol restored spine density of DG engram cells to control levels (AD + 100 Hz group; Fig. 3k , l). Furthermore, this spine restoration in early AD mice correlated with amelioration of long-term memory impairments observed during recall by natural cues (Fig. 3m ), an effect that persisted for at least 6 days after training (AD rescue + diphtheria toxin receptor (DTR) + saline group; Fig. 3p ). The LTP-induced spine restoration and behavioural deficit rescue were protein-synthesis dependent (Extended Data Fig. 7 ). The rescued memory was context-specific (Extended Data Fig. 8a ). In addition, long-term memory recall of agematched control mice was unaffected by this optical LTP protocol (Extended Data Fig. 8b ). By contrast, applying the optical LTP protocol to a large portion of excitatory PP terminals in the DG (that is, with no restriction to the PP terminals derived from EC engram cells) did not result in long-term memory rescue in early AD mice (Extended Data Fig.  9 ). To confirm the correlation between restoration of spine density of DG engram cells and amelioration of long-term memory impairments, which were both induced by the optical LTP protocol, we compared the overlap of natural-recall-cue-induced c-Fos + cells and CFC-training-labelled DG engram cells after an application of the engram-specific LTP protocol to early AD mice ( Fig. 3n ). Early AD mice that did not receive the optical LTP protocol showed low levels of c-Fos + /eYFP + overlap compared with control mice upon natural recall cue delivery. By contrast, early AD mice that went through the optical LTP protocol showed c-Fos + /eYFP + overlap similar to that of control mice ( Fig. 3n ). Thus, these data suggest that spine density restoration in DG engram cells contributes to the rescue of long-term memory in early AD mice.
Because of the highly redundant connectivity between the EC and DG 24 , it is possible that the extensive optical LTP protocol also augmented spine density in some non-engram DG cells. To establish a link between the spine rescue in DG engram cells and the behavioural rescue of early AD mice, we developed an engram-specific ablation 25 virus. We confirmed that this DTR-mediated method efficiently ablated DG engram cells after diphtheria toxin (DT) administration ( Fig. 3o ), while leaving the nearby DG mossy cells intact (Extended Data Fig. 10 ). By simultaneously labelling axonal terminals of PP with oChIEF and DG engram cells with DTR, we examined the effect of DG engram cell ablation after optical LTP-induced behavioural rescue ( Fig. 3p ). Within-animal comparisons (test 1 versus test 2) showed a decrease in freezing behaviour of LTP-rescued AD mice in which DG engram cells were ablated. These data strengthen the link between DG engram cells with restored spine density and long-term behavioural rescue in early AD mice.
To examine whether the optical LTP-induced behavioural rescue could be applied to DG engram cells from other learning experiences, we labelled memory engrams for inhibitory avoidance or novel object location in early AD mice ( Fig. 4a ). Early AD mice showed memory impairments in inhibitory avoidance memory and novel object location spatial memory (Fig. 4b, c ). Optical LTP-induced spine rescue at the PP-DG engram synapses was sufficient to reverse long-term memory impairments of early AD mice in both behavioural paradigms, thus demonstrating the versatility of our engram-based intervention.
Previous studies that examined the early stages of AD found correlations between memory impairments and synaptic pathology at the 
EC PP input into the DG 3,4,6 . It has been proposed that these early cognitive deficits are a failure of memory encoding on the basis of behavioural observations in human patients 8, 9 . However, we have shown that optogenetic activation of HPC cells active during learning elicits memory recall in mouse models of early AD. To our knowledge, this is the first rigorous demonstration that memory failure in early AD models reflects an impairment in the retrieval of information. Further support for a memory retrieval impairment in early AD comes from the fact that impairments are in LTM (at least 1 day long), but not in STM (~ 1 h after training), which is consistent with a retrieval deficit. The retrieval deficit in early AD models is similar to memory deficits observed in amnesia induced by impairing memory consolidation via protein synthesis inhibitors 14 . The underlying mechanism of memory failure in early AD patients may not necessarily parallel the molecular and circuit impairments observed in mouse models of early AD. For instance, some early AD patients can exhibit amyloid plaque deposition years before the onset of cognitive decline 9 . However, converging data on the underlying mechanism for genetically and pharmacologically induced amnesia in animal models increase the possibility that similar memory-retrieval-based failures may also operate in an early stage of AD patients. While we have shown that amnesia in early AD mice is a deficit of memory retrieval, it remains possible that the long-term maintenance of memory storage may also gradually become compromised as the disease proceeds from the early stage to more advanced stages, and eventually lost with neuronal degeneration. Further research will investigate these possibilities.
Our conclusions apply to episodic memory, which involves processing by HPC and other medial temporal lobe structures. In the literature 9 , it is widely recognized that early AD patients exhibit non-episodic memory deficits as well, which would involve brain structures other than the medial temporal lobe. Additional work is required to examine the mechanisms underlying cognitive impairments in these other types of memories. Nevertheless, our findings already contribute to a better understanding of memory retrieval deficits in several cases of early AD, and may apply to other pathological conditions, such as Huntington's disease 8 , in which patients show difficulty in memory recall.
Consistent with several studies highlighting the importance of dendritic spines 3,6,14,26 in relation to memory processing, we observed an engram-cell-specific decrease in spine density that correlated with 
memory deficits in early AD. Natural rescue of memory recall in early AD mice required the DG engram cells in which synaptic density deficits have been restored by in vivo optical LTP protocols applied to the EC cells activated during learning. By contrast, the application of optical LTP protocols to a much wider array of excitatory EC cells projecting to the DG, which may be analogous to deep brain stimulation, did not rescue memory in AD mice. A potential explanation for this observation is that DG granule cells may contribute to a variety of memories through their partially overlapping engram cell ensembles in a competitive manner, and that activation of a large number of these ensembles simultaneously may interfere with a selective activation of an individual ensemble. Thus, activation of a more targeted engram cell ensemble may be a key requirement for effective retrieval of the specific memory, which is difficult to achieve with the current deep brain stimulation strategy.
Genetic manipulations of specific neuronal populations can have profound effects on cognitive impairments of AD 27 . We propose that strategies applied to engram circuits can support long-lasting improvements in cognitive functions, which may provide insights and therapeutic value for future approaches that rescue memory in AD patients. 

METHODS
Subjects.
The APP/PS1 (ref. 10) double-transgenic AD mice, originally described as Line 85, were obtained from Jackson Laboratory (stock number 004462). Under the control of mouse prion promoter elements, these mice express a chimaeric mouse/human APP transgene containing Swedish mutations (K595N/M596L) as well as a mutant human PS1 transgene (delta exon 9 variant). To label memory engram cells in APP/PS1 mice, we generated a triple-transgenic mouse line by mating c-Fos-tTA 11,28 transgenic mice with APP/PS1 double-transgenic mice. The PS1/APP/tau 18 triple-transgenic AD mice were obtained from Jackson Laboratory (stock number 004807). These 3× Tg-AD mice express a mutant human PS1 transgene (M146V), a human APP transgene containing Swedish mutations (KM670/671NL) and a human MAPT transgene harbouring the P301L mutation. All mouse lines were maintained as hemizygotes. Mice had access to food and water ad libitum and were socially housed in numbers of two to five littermates until surgery. After surgery, mice were singly housed. For behavioural experiments, all mice were male and 7-9 months old. For optogenetic experiments, mice had been raised on food containing 40 mg kg −1 DOX for at least 1 week before surgery, and remained on DOX for the remainder of the experiments except for the target engram labelling days. For in vitro electrophysiology experiments, mice were 24-28 days old at the time of surgery. All experiments were conducted in accordance with US National Institutes of Health (NIH) guidelines and the Massachusetts Institute of Technology Department of Comparative Medicine and Committee of Animal Care. No statistical methods were used to predetermine sample size. Viral constructs. Our previously established method 11 for labelling memory engram cells combined c-Fos-tTA transgenic mice with a DOX-sensitive adenoassociated virus (AAV). However, in this study, we modified the method using a double-virus system to label memory engram cells in the early AD mice, which already carry two transgenes. The pAAV-c-Fos-tTA plasmid was constructed by cloning a 1 kb fragment from the c-Fos gene (550 bp upstream of c-Fos exon I to 35 bp into exon II) into an AAV backbone using the KpnI restriction site at the 5′ terminus and the SpeI restriction site at the 3′ terminus. The AAV backbone contained the tTA-Advanced 29 sequence at the SpeI restriction site. The pAAV-TRE-ChR2-eYFP and pAAV-TRE-eYFP constructs were previously described 11, 12 .
The pAAV-TRE-oChIEF-tdTomato 20 plasmid was constructed by replacing the ChR2-eYFP fragment from the pAAV-TRE-ChR2-eYFP plasmid using NheI and MfeI restriction sites. The pAAV-CaMKII-oChIEF-tdTomato plasmid was constructed by replacing the TRE fragment from the pAAV-TRE-oChIEF-tdTomato plasmid using BamHI and EcoRI restriction sites. The pAAV-TRE-DTR-eYFP 25 plasmid was constructed by replacing the ChR2 fragment from the pAAV-TRE-ChR2-eYFP plasmid using EcoRI and AgeI restriction sites. AAV vectors were serotyped with AAV 9 coat proteins and packaged at the University of Massachusetts Medical School Gene Therapy Center and Vector Core. Viral titres were 1.5 × 10 13 genome copy (GC) ml −1 for AAV 9 -c-Fos-tTA, AAV 9 -TRE-ChR2-eYFP and AAV 9 -TRE-eYFP, 1 × 10 13 GC ml −1 for AAV 9 -TRE-oChIEF-tdTomato, 4 × 10 13 GC ml −1 for AAV 9 -CaMKII-oChIEF-tdTomato and 2 × 10 13 GC ml −1 for AAV 9 -TRE-DTR-eYFP. Surgery and optic fibre implants. Mice were anaesthetized with isoflurane or 500 mg kg −1 avertin for stereotaxic injections 14 . Injections were targeted bilaterally to the DG (− 2.0 mm anteroposterior (AP), ± 1.3 mm mediolateral (ML), − 1.9 mm dorsoventral (DV)), MEC (− 4.7 mm AP, ± 3.35 mm ML, − 3.3 mm DV) and LEC (− 3.4 mm AP, ± 4.3 mm ML, − 4.0 mm DV). Injection volumes were 300 nl for DG and 400 nl for MEC and LEC. Viruses were injected at 70 nl min −1 using a glass micropipette attached to a 10 ml Hamilton microsyringe. The needle was lowered to the target site and remained for 5 min before beginning the injection. After the injection, the needle stayed for 10 min before it was withdrawn. A custom DG implant containing two optic fibres (200 mm core diameter; Doric Lenses) was lowered above the injection site (− 2.0 mm AP, ± 1.3 mm ML, − 1.7 mm DV). The implant was secured to the skull with two jewellery screws, adhesive cement (C&B Metabond) and dental cement. An opaque cap derived from the top part of an Eppendorf tube protected the implant. Mice were given 1.5 mg kg −1 metacam as analgesic and allowed to recover for 2 weeks before behavioural experiments. All injection sites were verified histologically. As criteria, we only included mice with virus expression limited to the targeted regions. Systemic injection of kainic acid. For seizure experiments 11 , mice were taken off DOX for 1 day and injected intraperitoneally with 15 mg kg −1 kainic acid (KA). Mice were returned to DOX food 6 h after KA treatment and perfused the next day for immunohistochemistry procedures. Immunohistochemistry. Mice were dispatched using 750-1,000 mg kg −1 avertin and perfused transcardially with PBS, followed by 4% paraformaldehyde (PFA). Brains were extracted and incubated in 4% PFA at room temperature overnight. Brains were transferred to PBS and 50-μ m coronal slices were prepared using a vibratome. For immunostaining 14 , each slice was placed in PBS + 0.2% Triton X-100 (PBS-T), with 5% normal goat serum for 1 h and then incubated with primary antibody at 4 °C for 24 h. Slices then underwent three wash steps for 10 min each in PBS-T, followed by 1 h incubation with secondary antibody. After three more wash steps of 10 min each in PBS-T, slices were mounted on microscope slides. All analyses were performed blind to the experimental conditions. Antibodies used for staining were as follows: to stain for ChR2-eYFP, DTR-eYFP or eYFP alone, slices were incubated with primary chicken anti-GFP (1:1,000, Life Technologies) and visualized using anti-chicken Alexa-488 (1:200) . For plaques, slices were stained using primary mouse anti-β -amyloid (1:1,000; Sigma-Aldrich) and secondary anti-mouse Alexa-488 (1:500). c-Fos was stained with rabbit antic-Fos (1:500, Calbiochem) and anti-rabbit Alexa-568 (1:300). Adult newborn neurons were stained with guinea pig anti-DCX (1:1,000; Millipore) and antiguinea-pig Alexa-555 (1:500). Neuronal nuclei were stained with mouse anti-NeuN Engram cells were labelled using c-Fos-tTA-driven synthesis of ChR2-eYFP or eYFP alone. The eYFP signal was amplified using immunohistochemistry procedures, after which fluorescence z-stacks were taken by confocal microscopy (Zeiss LSM700) using a × 40 objective. Maximum intensity projections were generated using ZEN Black software (Zeiss). Four mice per experimental group were analysed for dendritic spines. For each mouse, 30-40 dendritic fragments of 10-μ m length were quantified (n = 120-160 fragments per group). To measure spine density of DG engram cells with a focus on entorhinal cortical inputs, distal dendritic fragments in the middle-to-outer molecular layer (ML) were selected. For CA3 and CA1 engram cells, apical and basal dendritic fragments were selected. To compute spine density, the number of spines counted on each fragment was normalized by the cylindrical approximation of the surface of the specific fragment. Experiments were conducted blind to experimental group. Researcher 1 imaged dendritic fragments and randomized images, while researcher 2 performed manual spine counting. In vitro recordings. After isoflurane anaesthesia, brains were quickly removed and used to prepare sagittal slices (300 μ m) in an oxygenated cutting solution at 4 °C with a vibratome 14 data acquisition unit (Instrutech) running on custom software in Igor Pro (Wavemetrics). Data acquisition was suspended whenever the resting membrane potential was depolarized above − 50 mV or the access resistance (RA) exceeded 20 MΩ . Optogenetic stimulation was achieved using a 460 nm LED light source (Lumen Dynamics) driven by TTL input with a delay onset of 25 μ s (subtracted offline for latency estimation). Light power on the sample was 33 mW mm −2 .
To test oChIEF expression, EC cells were stimulated with a single light pulse of 1 s, repeated 10 times every 5 s. DG granule cells were held at − 70 mV. Optical LTP protocol: 5 min baseline (10 blue light pulses of 2 ms each, repeated every 30 s) was acquired before the onset of the LTP protocol (100 blue light pulses of 2 ms each at a frequency of 100 Hz, repeated 5 times every 3 min) and the effect on synaptic amplitude was recorded for 30 min (1 pulse of 2 ms every 30 s). Using the 5 min baseline recording data, EPSPs were normalized (Fig. 3j ). Potentiation was observed in 6 out of 30 cells and results were statistically confirmed using a two-tailed paired t-test. Experiments were performed in the presence of 10 μ M gabazine (Tocris) and 2 μ M CGP55845 (Tocris). Recorded cells were recovered for morphological identification using streptavidin CF633 (Biotium). In vivo recordings. Multi-unit responses to optical stimulation were recorded in the DG of mice injected with a cocktail of AAV 9 -c-Fos-tTA and AAV 9 -TRE-oChIEF-tdTomato viruses into MEC/LEC. Mice were anaesthetized (10 ml kg −1 ) using a mixture of ketamine (100 mg ml −1 )/xylazine (20 mg ml −1 ) and placed in the stereotactic system. Anaesthesia was maintained by booster doses of ketamine (100 mg kg −1 ). An optrode consisting of a tungsten electrode (0.5 MΩ ) attached to an optic fibre (200-μ m core diameter), with the tip of the electrode extending beyond the tip of the fibre by 300 μ m, was used for simultaneous optical stimulation and extracellular recording. The power intensity of light emitted from the optrode was calibrated to about 10 mW, consistent with the power used in behavioural assays. oChIEF + cells were identified by delivering 20-ms light pulses (1 Hz) to the recording site every 50-100 μ m. After light-responsive cells were detected, multi-unit activity in response to trains of light pulses (200 ms) at 100 Hz was recorded. Data acquisition used an Axon CNS Digidata 1440A system. MATLAB analysis was performed, as previously described 12 .
Behaviour assays. Experiments were conducted during the light cycle (7 a.m. to 7 p.m.). Mice were randomly assigned to experimental groups for specific behavioural assays immediately after surgery. Mice were habituated to investigator handling for 1-2 min on three consecutive days. Handling took place in the holding room where the mice were housed. Before each handling session, mice were transported by wheeled cart to and from the vicinity of the behaviour rooms to habituate them to the journey. For natural memory recall sessions, data were quantified using FreezeFrame software. Optogenetic stimulation interfered with the motion detection, and therefore all light-induced freezing behaviour was manually quantified. All behaviour experiments were analysed blind to experimental group. Unpaired Student's t-tests were used for independent group comparisons, with Welch's correction when group variances were significantly different. Given behavioural variability, initial assays were performed using a minimum of 10 mice per group to ensure adequate power for any observed differences. Experiments that resulted in significant behavioural effects were replicated three times in the laboratory. Following behavioural protocols, brain sections were prepared to confirm efficient viral labelling in target areas. Animals lacking adequate labelling were excluded before behaviour quantification. Contextual fear conditioning. Two distinct contexts were employed 14 ) , mice were placed on the light platform, which is the less preferred section of the chamber (relative to the grid section). Once mice entered the grid section of the chamber (all four feet), 0.80 mA shocks of 2 s duration were delivered. On average, each mouse received 2-3 shocks per training session. After 1 min, mice were returned to their home cage. The next day, latency to enter the grid section of the chamber as well as total time on the light platform was measured (3 min test). Novel object location. Spatial memory was measured in a white plastic chamber (28 × 28 cm) that had patterns (series of parallel lines or circles) on opposite walls. The apparatus was unscented and intermediate lighting was used. All mice were transferred to the behavioural room and acclimated for 30 min before the training session. On day 1, mice were allowed to explore the chamber with patterns for 15 min. On days 2 and 3, mice were introduced into the chamber that had an object (7-cm-tall glass flask filled with metal beads) placed adjacent to either patterned wall. The position of the object was counter-balanced within each genotype. On day 4, mice were placed into the chamber with the object either in the same position as the previous exposure (familiar) or at a novel location based on wall patterning. Frequency of visits to the familiar and novel object locations was quantified using an automated detection system (EthoVision XT, Noldus). Total time exploring the object was also measured (nose within 1.5 cm of object). The tracking software plotted heat maps based on exploration time, which was averaged to create representative heat maps for each genotype. Raw data were extracted and analysed using Microsoft Excel.
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Extended Data Figure 3 | Chronic DG engram activation in early AD mice did not rescue long-term memory. a, Behavioural schedule for repeated DG engram activation experiment. Ctx, context. b, AD mice in which a DG memory engram was reactivated twice a day for 2 days (AD + ChR2) showed increased STM freezing levels compared with memory recall before engram reactivation (ChR2-STM test, n = 9 mice per group). c, Memory recall 1 day after repeated DG engram activations (ChR2-LTM test). NS, not significant. Statistical comparisons are performed using unpaired t-tests; * P < 0.05, * * P < 0.01. Data are presented as mean ± s.e.m.
Extended Data Figure 4 | Engram activation restores fear memory in triple-transgenic and PS1/APP/tau models of early AD. a, Tripletransgenic mouse line obtained by mating c-Fos-tTA transgenic mice 11, 28 with double-transgenic APP/PS1 AD mice 10 . These mice combined with a DOX-sensitive AAV virus permits memory engram labelling in early AD. b, Triple-transgenic mice were injected with AAV 9 -TRE-ChR2-eYFP and implanted with an optic fibre targeting the DG. c, Image showing DG engram cells of triple-transgenic mice 24 h after CFC. d, ChR2-eYFP cell counts from control and triple-transgenic AD mice (n = 5 mice per group). e, Behavioural schedule for engram activation. f, Memory recall 1 day after training (test 1) showed less freezing of triple-transgenic AD mice compared with control mice (n = 10 mice per group). g, Engram activation with blue light stimulation (left). Average freezing for the two light-off and light-on epochs (right). h, Triple-transgenic AD model (3× Tg-AD) as previously reported 18 . A cocktail of AAV 9 -c-Fos-tTA and AAV 9 -TRE-ChR2-eYFP viruses were used to label memory engrams in 3× Tg-AD mice. i, Image showing memory engram cells in the DG of 3× Tg-AD mice 24 h after CFC. j, ChR2-eYFP cell counts from DG sections of control and 3× Tg-AD mice (n = 4 mice per group). k, Behavioural schedule for engram activation. l, Memory recall 1 day after training (test 1) showed less freezing of 3× Tg-AD mice compared with control mice (n = 9 mice per group). m, Engram activation with blue light stimulation (left). Average freezing for the two light-off and light-on epochs (right). Statistical comparisons are performed using unpaired t-tests; * P < 0.05, * * P < 0.01. Data are presented as mean ± s.e.m.
